Journal of the Pediatric Infectious Diseases Society (JPIDS) Volume 6, Issue 4 December 2017

Journal of the Pediatric Infectious Diseases Society (JPIDS)
Volume 6, Issue 4   December 2017
https://academic.oup.com/jpids/issue

ORIGINAL ARTICLES
Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland
Maria Hemming-Harlo; Timo Vesikari; Matti Uhari; Marjo Renko; Marjo Salminen
Journal of the Pediatric Infectious Diseases Society, Volume 6, Issue 4, 24 November 2017, Pages 317–323, https://doi.org/10.1093/jpids/piw061

Missed Opportunities for Human Papillomavirus Vaccine Initiation in an Insured Adolescent Female Population
Claudia M Espinosa; Gary S Marshall; Charles R Woods; Qianli Ma; Derek Ems
Journal of the Pediatric Infectious Diseases Society, Volume 6, Issue 4, 24 November 2017, Pages 360–365, https://doi.org/10.1093/jpids/pix067
In this cohort of nearly 15000 11-year-old girls with insurance (commercial or Medicaid), the human papillomavirus vaccine was administered at only 1 in 4 well-adolescent visits and approximately one-third of vaccine-related visits, which suggests a substantial number of missed opportunities.

LITERATURE REVIEW
Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature
Tomohiro Katsuta; Yusuke Miyaji; Paul A Offit; Kristen A Feemster
Journal of the Pediatric Infectious Diseases Society, Volume 6, Issue 4, 24 November 2017, Pages 380–385, https://doi.org/10.1093/jpids/pix063
Current evidence to support the efficacy of adjuvant therapies, including therapeutic use of the quadrivalent human papillomavirus vaccine, for juvenile-onset recurrent respiratory papillomatosis is inconsistent. Prophylactic use of the currently available human papillomavirus vaccine in adolescents is the most effective strategy for preventing JoRRP among their children in the future.